➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
AstraZeneca
McKinsey
Boehringer Ingelheim
Mallinckrodt

Last Updated: May 15, 2021

DrugPatentWatch Database Preview

Litigation Details for Shire Development LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Shire Development LLC v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Get Started for $10 and   Get Started for $10 .

Details for Shire Development LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-11-21 1 United States Patent Nos. 6,913,768 (“the ’768 patent”), 8,846,100 (“the ’100 patent”), and 9,173,857…(“Shire”), as the record owner of U.S. Patent Nos. 6,913,768, 8,846,100, and 9,173,857.” 46.… This is a civil action for patent infringement arising under the patent laws of the United States, …’857 patent”), attached hereto as Exhibits A, B, and C, respectively (collectively, “the patents in suit…Plaintiff Shire LLC owns the ’768 patent. 38. The ’100 patent, entitled “Controlled Dose Drug External link to document
2019-02-27 109 in U.S. Patent Nos. 6,913,768 ('"768 Patent"), 8,846,100 ("'100 Patent"),…construction for multiple terms in U.S. Patent Nos. 6,913,768, 8,846,100, and 9,173,857. Within five days…claim 1 of the ' 100 Patent and claim 1 of the ' 857 Patent. The Patents relate to "a long-acting…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2019-06-21 184 Notice of Service Invalidity Contentions for U.S. Patent No. 8,846,100 and U.S. Patent No. 9,173,857 filed by Actavis Laboratories…2017 8 November 2019 1:17-cv-01696 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-11-07 205 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,913,768 B2; 8,846,100 B2; 9,173,857…2017 8 November 2019 1:17-cv-01696 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Colorcon
AstraZeneca
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.